Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Gastroenterology. 2010 Jan 25;138(5):1854–1862. doi: 10.1053/j.gastro.2010.01.035

Table 4. Mutation in the RAS-RAF pathway in hereditary and sporadic CRC tumors.

P < 0.001 for BRAF and KRAS comparisons among CRC groups. P = 0.001 for codon 12 and P = 0.033 for codon 13 comparisons among groups.

BRAF mutation KRAS mutation codon 12 codon 13
MSS HNPCC 0% 31.8% (7) 31.8% (7) 0%
Lynch syndrome 0% 9.5% (2) 9.5% (2) 0%
MSI sporadic 28.3% (13) 4.4% (2) 2.2% (1) 2.2% (1)
MSS sporadic 2.2% (2) 39.2% (36) 27.2% (25) 12% (11)